EOT

DGAP-News: Advanced Blockchain´s portfolio company peaq receives $6 million in further funding

Retrieved on: 
Wednesday, June 29, 2022
Gaia, USD, EOT, Dapp, Ecosystem, Industry, ISIN, DAPP, Association, VCS, Traction, Investment, MOBI, GAIA-X, News, High-resolution audio, XETRA, GSR, DGAP, Time, Economy, Blockchain, Security (finance), Cryptocurrency, Polka dot, Web3

Advanced Blockchain AG (Scale Frankfurt, Primary Market Dsseldorf, XETRA: ISIN DE000A0M93V6) announces that its portfolio company - the Web3 network peaq - recently raised USD 6 million from Fundamental Labs, HashKey, Delta VC, GSR, Cypher Capital and other notable VCs.

Key Points: 
  • Advanced Blockchain AG (Scale Frankfurt, Primary Market Dsseldorf, XETRA: ISIN DE000A0M93V6) announces that its portfolio company - the Web3 network peaq - recently raised USD 6 million from Fundamental Labs, HashKey, Delta VC, GSR, Cypher Capital and other notable VCs.
  • The funding will support the continued expansion of the peaq network.
  • Advanced Blockchain now holds about 6% of all tokens and still holds about 37% of Peaq Technology GmbH.
  • The capital will be used to expand the development team and launch new products and features in the peaq ecosystem.

Kezar Life Sciences Announces Positive Topline Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib for the Treatment of Patients with Lupus Nephritis

Retrieved on: 
Monday, June 27, 2022
Science, Other Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Clinical Trials, Diagnosis, Death, Fever, Migraine, Patient, ORR, SLE, Dialysis, Immunosuppression, Biomarker, EGFR, Nausea, Șaeș, CRR, U.S. Securities and Exchange Commission, Disease, UPCR, Vomiting, Acute kidney injury, Chronic kidney disease, Degenerative disease, Association, Risk, Investor, Sec61, Headache, Clinical trial, Private Securities Litigation Reform Act, List of life sciences, EOT, Glomerular filtration rate, Proteinuria, Nasdaq, Lupus nephritis, Urinary tract infection, Autoimmune disease, Week, Lupus, Webcast, Injection site reaction, Safety, Forward-looking statement, Pharmaceutical industry, Medical imaging, LN

The MISSION Phase 2 topline results show a clinically meaningful overall renal response to zetomipzomib after 6 months, without high-dose induction therapy.

Key Points: 
  • The MISSION Phase 2 topline results show a clinically meaningful overall renal response to zetomipzomib after 6 months, without high-dose induction therapy.
  • Based on the strength of these results, we plan to continue developing zetomipzomib for patients with lupus nephritis, as well as evaluate development opportunities for systemic lupus erythematosus.
  • The MISSION Phase 2 clinical trial is an open-label study designed to demonstrate the responder rate of zetomipzomib in patients with active LN.
  • Patients in the MISSION Phase 2 clinical trial received zetomipzomib without induction therapy, which represents a significant difference from other recently published trials in LN.

Atlas Technology Group Becomes Long-Term Node Host for peaq

Retrieved on: 
Friday, June 17, 2022
Technology, Networks, Web3, Other Technology, Ethereum, Tezos, Time, Economy, Development, Atlas, Technology, Internet, High-resolution audio, Human, API, DAPP, Ecosystem, Partnership, Avalanche, EOT, Automation, Music Technology Group, Web3, Semantic Web, Dapp, Income, Cryptocurrency, Renewable energy, Cosmos

Atlas will host peaq nodes to support peaqs network and ecosystem, driving the emergence of the Economy of Things.

Key Points: 
  • Atlas will host peaq nodes to support peaqs network and ecosystem, driving the emergence of the Economy of Things.
  • Atlas will also be actively involved in staking, data storage, API support and supplying projects in the peaq ecosystem with required resources for development.
  • peaq is leading the charge into the Economy of Things, and Atlas is supporting that charge.
  • As one of the youngest projects supported by Atlas, peaq stands alongside industry-defining projects such as Solana, Ethereum, Cosmos, Tezos and Avalanche.

Pear Presents Interim Real-World Data Showing Significant Reductions in Symptoms of Chronic Insomnia, Anxiety and Depression with Somryst® at SLEEP 2022

Retrieved on: 
Wednesday, June 8, 2022
Biotechnology, Technology, FDA, Health, General Health, Pharmaceutical, Mental Health, Research, Software, Science, Clinical Trials, DREAM, Adult, Anxiety, Insomnia, MBA, Depression, Cognitive behavioral therapy, Associated, EOT, Nasdaq, Therapy, FDA, Patient, PDT, MD, Clinical trial, ISI, Interim, Pharmaceutical industry, Development

Chronic insomnia is often associated with depression and anxiety so its important to evaluate the impact of insomnia treatment on such psychiatric comorbidities.

Key Points: 
  • Chronic insomnia is often associated with depression and anxiety so its important to evaluate the impact of insomnia treatment on such psychiatric comorbidities.
  • Data cutoff for this interim analysis was January 20, 2022.
  • Somryst is the only FDA-authorized therapeutic that delivers guideline recommended first-line treatment for chronic insomnia.
  • Sleep Restriction (and Consolidation) within Somryst can cause sleepiness, especially in the early stages of using the PDT.

Pear Therapeutics Announces Data from Two Studies Evaluating Prescription Digital Therapeutics (PDTs) for Chronic Insomnia Presented at World Sleep Congress 2022

Retrieved on: 
Tuesday, March 15, 2022
Software, Biotechnology, Pharmaceutical, Health, Mental Health, Technology, Clinical Trials, Other Health, DREAM, Therapy, Quality of life, Depression, International, World, Patient, PDT, S31, FDA, EOT, Interim, Suicide, ISI, Digital, SOL, Nasdaq, WASO, Clinical trial, Hypertension, Population, Congress, Heart, CBT, Pear, Sleep, Pharmaceutical industry, Insomnia

Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced data that further underscore the effectiveness of Somryst, the only FDA-authorized PDT for the treatment of chronic insomnia.

Key Points: 
  • Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced data that further underscore the effectiveness of Somryst, the only FDA-authorized PDT for the treatment of chronic insomnia.
  • Interim data from the DREAM study (NCT04325464), a remote, virtual, open-label, decentralized clinical trial evaluating Somryst, analyzed in mid-Q1 2022, had 991 patients enrolled to date.
  • These results demonstrate that cognitive behavioral therapy, the recommended first line treatment of care for chronic insomnia, can be effectively delivered through a PDT like Somryst, helping patients treat their chronic insomnia.
  • An additional study evaluating older adults (55 years of age or older) with chronic insomnia was also presented.

Oyu Tolgoi partners reach comprehensive agreement and approve commencement of underground mining operations

Retrieved on: 
Monday, January 24, 2022
Natural Resources, Alternative Energy, Energy, Mining, Minerals, Utilities, Australasian Institute of Mining and Metallurgy, Competence, JORC, Tax, Heads of Agreement (1981), Agreement, Treaty of friendship and alliance between the Government of Mongolia and Tibet, Environment, OT, Government, COVID-19, Minerals Resource Rent Tax, Australian Securities Exchange, Interim, Rio Tinto, Annual report, ESG, State, Copper, Intention, Heads of Agreement, EOT, United Nations Security Council Resolution 103, Group, Competent person, Panel, TRQ, Private Securities Litigation Reform Act, Hand, Metallurgy, Budget, Investment, Income, Person, United Nations Security Council Resolution 92, ASX, Financial Conduct Authority, Parliament, UK, Classification, Employment, UDP, Workforce, Risk, Electrical energy, Mining, Bank, Risk management, Cryptocurrency, Security (finance), Iron ore, Oyu Tolgoi mine, Mining, Turquoise Hill Resources, Mineral

As a result, the OT Board, comprised of representatives of Rio Tinto, TRQ and Erdenes Oyu Tolgoi (EOT) which is wholly owned by the Government of Mongolia, has unanimously approved commencement of underground operations.

Key Points: 
  • As a result, the OT Board, comprised of representatives of Rio Tinto, TRQ and Erdenes Oyu Tolgoi (EOT) which is wholly owned by the Government of Mongolia, has unanimously approved commencement of underground operations.
  • An updated funding plan has been agreed to address TRQs current estimated remaining funding requirement for the OT Underground Project.
  • Rio Tinto and TRQ have amended the Heads of Agreement signed in April 2021 to ensure they appropriately fund OT.
  • Luvsannamsrain Oyun-Erdene, the Prime Minister of Mongolia, said, The commencement of Oyu Tolgoi underground mining operations demonstrates to the world that Mongolia can work together with investors in a sustainable manner and become a trusted partner.

Project Equity launches new financing option to help local businesses build for the future

Retrieved on: 
Thursday, September 2, 2021
Foundation, Awareness, CDFI, The, ESOP, Silver, IDFC Project Equity, Income, Family, Share capital, Color, Employee stock ownership, Racism, CA, EOT, Movement, Investment, Data analysis, Retirement, Holey Artisan Bakery, CEO, Ownership, Sale, Nightwatch in the Living City, Growth, Gaps, Employee ownership trust, Management, Bank, Insurance, Security (finance)

Project Equity, a national leader in the movement to expand employee ownership has launched a new initiative to provide flexible capital to companies on the path to employee ownership.

Key Points: 
  • Project Equity, a national leader in the movement to expand employee ownership has launched a new initiative to provide flexible capital to companies on the path to employee ownership.
  • The Employee Ownership Catalyst Fund provides working capital and transaction financing to businesses with 25-100+ employees.
  • While the past year has been challenging, savvy business owners see the opportunity now to build for the future by transitioning to employee ownership.
  • Project Equity is a national leader in the movement to harness employee ownership to maintain thriving local business communities and address income and wealth inequality.

Radar Tech Firm Cambridge Pixel Switches to Employee Ownership to Secure Long-term Future

Retrieved on: 
Tuesday, November 10, 2020
Mobile phones, Google Pixel, Smartphones, Mobile computers, Android, Pixel, EOT, Litlington, Cambridge, Massachusetts

"The establishment of employee ownership through the EOT at Cambridge Pixel will provide continued job security for all staff," said David Johnson.

Key Points: 
  • "The establishment of employee ownership through the EOT at Cambridge Pixel will provide continued job security for all staff," said David Johnson.
  • Dr Johnson believes that employee ownership also bodes well for customers and will help to secure the long-term future of the company.
  • Cambridge Pixel provides software licences for radar display and tracking to major commercial and defence companies the world-over.
  • Cambridge Pixel is headquartered at New Cambridge House in Litlington, near Cambridge in the UK, and operates worldwide through a network of agents and distributors.

Radar Tech Firm Cambridge Pixel Switches to Employee Ownership to Secure Long-term Future

Retrieved on: 
Tuesday, November 10, 2020
Mobile phones, Google Pixel, Smartphones, Mobile computers, Android, Pixel, EOT, Litlington, Cambridge, Massachusetts

"The establishment of employee ownership through the EOT at Cambridge Pixel will provide continued job security for all staff," said David Johnson.

Key Points: 
  • "The establishment of employee ownership through the EOT at Cambridge Pixel will provide continued job security for all staff," said David Johnson.
  • Dr Johnson believes that employee ownership also bodes well for customers and will help to secure the long-term future of the company.
  • Cambridge Pixel provides software licences for radar display and tracking to major commercial and defence companies the world-over.
  • Cambridge Pixel is headquartered at New Cambridge House in Litlington, near Cambridge in the UK, and operates worldwide through a network of agents and distributors.

Frost & Sullivan Webinar: Identify Grid Modernization Initiatives Supporting Growth in the Electrification of Transportation

Retrieved on: 
Wednesday, November 14, 2018
Electric power distribution, Electrical grid, EOT

SANTA CLARA, California, Nov. 14, 2018 /PRNewswire/ --Frost & Sullivan's Energy & Environment team will host a live, complimentary briefing, Identifying Key Growth Opportunities for Electrification of Transportation, on Thursday, November 15, at 2:00 PM EST.

Key Points: 
  • SANTA CLARA, California, Nov. 14, 2018 /PRNewswire/ --Frost & Sullivan's Energy & Environment team will host a live, complimentary briefing, Identifying Key Growth Opportunities for Electrification of Transportation, on Thursday, November 15, at 2:00 PM EST.
  • The interactive briefing will be hosted by Frost & Sullivan's Farah Saeed, research director for digital grids and Naren Pasupalati, senior research analyst.
  • Regardless, there is a growing positive sentiment and a sense of urgency to embrace electrification of transportation (EoT) coming from the consumer and electric grid sides.
  • For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community.